Evidence map›Paper›PMID 26241322›Full record

ArticleThe Journal of clinical endocrinology and metabolism2015

Bone Mineral Accrual Is Associated With Parathyroid Hormone and 1,25-Dihydroxyvitamin D Levels in Children and Adolescents.

Mark D DeBoer, David R Weber, Babette S Zemel, Michelle R Denburg, Rita Herskovitz, Jin Long, Mary B Leonard

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Insulin-like growth factors: actions on the skeleton.Journal of molecular endocrinology · 2018
    Review
  7. Article
  8. Article
  9. Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mark D DeBoerDepartment of Pediatrics (M.D.D.), University of Virginia, Charlottesville, Virginia 22908; Department of Pediatrics (D.R.W.), University of Rochester, Rochester, New York 14642; Department of Pediatrics (B.S.Z., M.R.D., R.H., J.L.), The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104; and Departments of Pediatrics and Medicine (M.B.L.), Stanford University, Stanford, California 94305.
David R WeberDepartment of Pediatrics (M.D.D.), University of Virginia, Charlottesville, Virginia 22908; Department of Pediatrics (D.R.W.), University of Rochester, Rochester, New York 14642; Department of Pediatrics (B.S.Z., M.R.D., R.H., J.L.), The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104; and Departments of Pediatrics and Medicine (M.B.L.), Stanford University, Stanford, California 94305.
Babette S ZemelDepartment of Pediatrics (M.D.D.), University of Virginia, Charlottesville, Virginia 22908; Department of Pediatrics (D.R.W.), University of Rochester, Rochester, New York 14642; Department of Pediatrics (B.S.Z., M.R.D., R.H., J.L.), The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104; and Departments of Pediatrics and Medicine (M.B.L.), Stanford University, Stanford, California 94305.
Michelle R DenburgDepartment of Pediatrics (M.D.D.), University of Virginia, Charlottesville, Virginia 22908; Department of Pediatrics (D.R.W.), University of Rochester, Rochester, New York 14642; Department of Pediatrics (B.S.Z., M.R.D., R.H., J.L.), The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104; and Departments of Pediatrics and Medicine (M.B.L.), Stanford University, Stanford, California 94305.
Rita HerskovitzDepartment of Pediatrics (M.D.D.), University of Virginia, Charlottesville, Virginia 22908; Department of Pediatrics (D.R.W.), University of Rochester, Rochester, New York 14642; Department of Pediatrics (B.S.Z., M.R.D., R.H., J.L.), The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104; and Departments of Pediatrics and Medicine (M.B.L.), Stanford University, Stanford, California 94305.
Jin LongDepartment of Pediatrics (M.D.D.), University of Virginia, Charlottesville, Virginia 22908; Department of Pediatrics (D.R.W.), University of Rochester, Rochester, New York 14642; Department of Pediatrics (B.S.Z., M.R.D., R.H., J.L.), The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104; and Departments of Pediatrics and Medicine (M.B.L.), Stanford University, Stanford, California 94305.
Mary B LeonardDepartment of Pediatrics (M.D.D.), University of Virginia, Charlottesville, Virginia 22908; Department of Pediatrics (D.R.W.), University of Rochester, Rochester, New York 14642; Department of Pediatrics (B.S.Z., M.R.D., R.H., J.L.), The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104; and Departments of Pediatrics and Medicine (M.B.L.), Stanford University, Stanford, California 94305.
Stanford University · US

Funding

INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR024134 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2006 to 2011
$70.4M
ZDV VS ZDV + DDL VS ZDV + DDL + NVP IN ASYMPTOMATIC HIV PATIENTSM01RR000040 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 1985 to 2006
$21.1M
Translational Research Training in Pediatric Diabetes & EndocrinologyT32DK063688 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI LORRAINE E LEVITT KATZ, ANDREA Bridget KELLY · 2002 to 2026
$5.4M
STRUCTURAL EFFECTS OF RENAL OSTEODYSTROPHY DURING GROWTHR01HD040714 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI LEONARD, MARY BETH · 2002 to 2006
$2.6M
Translational Molecular Pediatric ResearchK12HD068373 · NICHD · UNIVERSITY OF ROCHESTER · PI SCHOR, NINA F · 2011 to 2015
$2.0M
GLUCOCORTICOID-INDUCED OSTEOPENIA IN CHILDRENR01DK060030 · NIDDK · CHILDRENS HOSPITAL OF PHILADELPHIA · PI LEONARD, MARY BETH · 2001 to 2005
$1.8M
Patient Oriented Research in Vitamin D Deficiency in CKDK24DK076808 · NIDDK · STANFORD UNIVERSITY · PI LEONARD, MARY BETH · 2007 to 2016
$1.7M
Vitamin D Deficiency in Glomerular DiseaseK23DK093556 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI DENBURG, MICHELLE · 2012 to 2016
$858k
Inflammatory Mechanisms of Puberty Dysregulation in ColitisK08HD060739 · NICHD · UNIVERSITY OF VIRGINIA · PI DEBOER, MARK DANIEL · 2009 to 2013
$649k
Muscle & Bone Mass Changes after TNF-a Inhibition in Pediatric Crohn DiseaseK23DK082012 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI THAYU, MEENA · 2008 to 2011
$588k
NCRR NIH HHS M01 RR000040NCRR NIH HHS UL1 RR024134NCRR NIH HHS UL1-RR-024134NICHD NIH HHS K08 HD060739NICHD NIH HHS K08-HD060739NICHD NIH HHS K12 HD068373NICHD NIH HHS R01 HD040714NICHD NIH HHS R01-HD040714NIDDK NIH HHS K23 DK082012NIDDK NIH HHS K23 DK093556NIDDK NIH HHS K23-DK093556NIDDK NIH HHS K24 DK076808NIDDK NIH HHS K24-DK076808NIDDK NIH HHS R01 DK060030NIDDK NIH HHS R01-DK060030NIDDK NIH HHS T32 DK063688
6 · The paper itself

Abstract

contextRapid bone accrual and calcium demands during puberty may result in compensatory increases in PTH and 1,25-dihydroxyvitamin D [1,25(OH)2D] levels; however, these relations have not been established in longitudinal studies.

objectiveTo determine whether greater bone accrual velocity is associated with greater PTH and 1,25(OH)2D levels in healthy children and adolescents.

designProspective cohort study with baseline PTH, 25-hydroxyvitamin D [25(OH)D], and 1,25(OH)2D levels and dual-energy x-ray absorptiometry whole-body bone mineral content (BMC) accrual over 12 months. Secondary analyses examined bone biomarkers and tibia quantitative computed tomography midshaft cortical-BMC.

participantsA total of 594 healthy participants, ages 5-21 years, with longitudinal measures in a subset of 145 participants.

main outcome measuresPTH and 1,25(OH)2D levels.

resultsPTH levels were higher during Tanner stages 3 and 4 compared to Tanner 1 (P < .05) in males and females and were inversely and significantly associated with 25(OH)D levels and dietary calcium intake. In multivariable analyses, greater bone accrual [measured directly as change in dual-energy x-ray absorptiometry-BMC (P < .001) or quantitative computed tomography-BMC (P < .05), or indirectly as growth velocity (P < .05) or greater bone-formation biomarker level (P < .01)] was associated with higher PTH levels, independent of 25(OH)D level and dietary calcium intake. Similar associations were observed between these direct and indirect indices of bone accrual and 1,25(OH)2D levels.

conclusionsPTH levels rise in midpuberty, in association with multiple measures of bone accrual. This is consistent with compensatory increases in PTH to drive 1,25(OH)2D production and calcium absorption during periods of increased calcium demands. Additional studies are needed to address PTH effects on bone modeling and remodeling during growth and development.

Indexed as

AdolescentBone DensityBone DevelopmentCalcification, PhysiologicChildChild, PreschoolFemaleHumansMaleParathyroid HormonePubertyVitamin DYoung Adult1,25-dihydroxyvitamin DParathyroid HormoneVitamin D

Identifiers

PMID26241322
PMCPMC4596042
OpenAlexW1835027475

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.